Irina Bondar

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Maria Fleseriu, Alexander Dreval, Irina Bondar et al. · The Lancet Diabetes & Endocrinology · 2021 · 49 citations · Full text

Allergy, Injectable Somatostatin Receptor, Clinical Trials +3

Primary hyperparathyroidism in Russia according to the registry

Natalia Mokrysheva, Svetlana Mirnaya, Ekaterina Dobreva et al. · Problems of Endocrinology · 2019 · 40 citations · Full text

[Urinary excretion of proinflammatory cytokines and transforming growth factor beta at early stages of diabetic nephropathy].

Irina Bondar, Vadim V. Klimontov · PubMed · 2008 · 18 citations

[Obesity and chronic kidney disease].

Irina Bondar, Vadim V. Klimontov · PubMed · 2011 · 10 citations

Glomerular Disease, Hypertension, Renal Pathology +16